"Pulse Therapy, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of high doses of pharmaceuticals over short periods of time.
| Descriptor ID |
D020551
|
| MeSH Number(s) |
E02.319.283.600
|
| Concept/Terms |
Pulse Therapy, Drug- Pulse Therapy, Drug
- Drug Pulse Therapies
- Pulse Therapies, Drug
- Therapies, Drug Pulse
- Therapy, Drug Pulse
- Pulse Drug Therapy
- Drug Therapies, Pulse
- Drug Therapy, Pulse
- Pulse Drug Therapies
- Therapies, Pulse Drug
- Therapy, Pulse Drug
- Drug Pulse Therapy
|
Below are MeSH descriptors whose meaning is more general than "Pulse Therapy, Drug".
Below are MeSH descriptors whose meaning is more specific than "Pulse Therapy, Drug".
This graph shows the total number of publications written about "Pulse Therapy, Drug" by people in this website by year, and whether "Pulse Therapy, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulse Therapy, Drug" by people in Profiles.
-
An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma. Int J Hematol. 2022 Mar; 115(3):391-398.
-
Everolimus-induced pneumonitis: A diagnostic challenge. Breast J. 2020 02; 26(2):287-288.
-
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr Nephrol. 2019 11; 34(11):2343-2350.
-
What's in a name? Surv Ophthalmol. 2016 Jan-Feb; 61(1):95-101.
-
Neglected tropical skin diseases: their global elimination through integrated mass drug administration? JAMA Dermatol. 2014 May; 150(5):481-2.
-
Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy. Pediatr Nephrol. 2007 Jul; 22(7):981-6.
-
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9.
-
Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant. 2000 Sep; 26(5):573-6.